The Association of Cortisol with Prevalent and Incident Type 2 Diabetes in Older Community-Dwelling Adults
DOI:
https://doi.org/10.12974/2313-0946.2016.03.01.1Keywords:
Cortsiol, type 2 diabetes, prevalent cases, incident casesAbstract
Context: Previous studies report cross-sectional associations between circulating cortisol levels and type 2 diabetes in older adults; none assessed the association prospectively.
Objective: This study’s objective was to examine the association of serum cortisol with prevalent and incident diabetes in community-dwelling older adults.
Methods: Between 1984-87, 885 men and 729 women aged 50 or older had serum fasting morning cortisol measured and an oral glucose tolerance test administered at a baseline research clinic visit and were followed for up to 25 years. Logistic and cox proportional hazards regression models were used to assess cortisol associations with prevalent and incident diabetes.
Results: Median age of participants was 75 years, median body mass index was 25kg/m2, and median cortisol was 91mg/ml. At baseline, 249 participants had prevalent diabetes; 118 developed diabetes during follow-up. In unadjusted analyses, the odds of prevalent diabetes for the highest cortisol quartile compared to the lowest was 1.95 (95% CI: 1.32, 2.87) and remained significant after adjusting for age, sex and diabetes risk factors (OR: 1.85, 95% CI: 1.21, 2.83); associations were not significant for the second and third quartiles. Serum cortisol was not associated with incident diabetes before or after adjusting for covariates (fully-adjusted HR for highest versus lowest quartile=1.02, 95% CI: 0.58, 1.78).
Conclusions: Results suggest that in older adults, elevated cortisol levels may be a result of diabetes and its complications, rather than a cause. Further studies using cohorts with repeated cortisol measures are needed to confirm the direction of the hypercortisolemia-diabetes link.
References
National Diabetes Statistics Report. Ed CfDCa Prevention, 2014.
Stewart P. The adrenal cortex. In William's textbook of endocrinology, edn 11th, ch. 14. USA: Saunders/Elesevier, 2008.
Arnaldi G, Angeli A, Atkinson AB, Bertagna X, Cavagnini F, Chrousos GP, et al. Diagnosis and complications of Cushing's syndrome: a consensus statement. Journal of Clinical Endocrinology and Metabolism 2003 88 5593-5602. http://dx.doi.org/10.1210/jc.2003-030871
Champaneri S, Xu X, Carnethon MR, Bertoni AG, Seeman T, Diez Roux A, et al. Diurnal salivary cortisol and urinary catecholamines are associated with diabetes mellitus: the Multi-Ethnic Study of Atherosclerosis. Metabolism: Clinical and Experimental 2012; 61: 986-995. http://dx.doi.org/10.1016/j.metabol.2011.11.006
Schoorlemmer RM, Peeters GM, van Schoor NM and Lips P. Relationships between cortisol level, mortality and chronic diseases in older persons. Clinical Endocrinology 2009; 71: 779-786. http://dx.doi.org/10.1111/j.1365-2265.2009.03552.x
Prpic-Krizevac I, Canecki-Varzic S and Bilic-Curcic I. Hyperactivity of the hypothalamic-pituitary-adrenal axis in patients with type 2 diabetes and relations with insulin resistance and chronic complications. Wien Klin Wochenschr 2012; 124: 403-411. http://dx.doi.org/10.1007/s00508-012-0191-4
Chiodini I, Torlontano M, Scillitani A, Arosio M, Bacci S, Di Lembo S, et al. Association of subclinical hypercortisolism with type 2 diabetes mellitus: a case-control study in hospitalized patients. European Journal of Endocrinology of the European Federation of Endocrine Societies 2005; 153: 837-844. http://dx.doi.org/10.1530/eje.1.02045
Hackett RA, Steptoe A and Kumari M. Association of diurnal patterns in salivary cortisol with type 2 diabetes in the Whitehall II study. Journal of Clinical Endocrinology and Metabolism 2014; 99: 4625-4631. http://dx.doi.org/10.1210/jc.2014-2459
Beck AT, Ward CH, Mendelson M, Mock J and Erbaugh J. An inventory for measuring depression. Archives of General Psychiatry 1961; 4: 561-571. http://dx.doi.org/10.1001/archpsyc.1961.01710120031004
Taylor J. The hypertension detection and follow-up program: a progress report. Circulation Research 1977; 40: I106-109.
Chiodini I, Adda G, Scillitani A, Coletti F, Morelli V, Di Lembo S, et al. Cortisol secretion in patients with type 2 diabetes: relationship with chronic complications. Diabetes Care 2007; 30: 83-88. http://dx.doi.org/10.2337/dc06-1267
Chiodini I, Di Lembo S, Morelli V, Epaminonda P, Coletti F, Masserini B, et al. Hypothalamic-pituitary-adrenal activity in type 2 diabetes mellitus: role of autonomic imbalance. Metabolism: Clinical and Experimental 2006; 55: 1135-1140. http://dx.doi.org/10.1016/j.metabol.2006.04.010
Fruehwald-Schultes B, Kern W, Born J, Fehm HL and Peters A. Hyperinsulinemia causes activation of the hypothalamus-pituitary-adrenal axis in humans. International Journal of Obesity and Related Metabolic Disorders 2001; 25(1): S38-40. http://dx.doi.org/10.1038/sj.ijo.0801695
Barrett-Connor E. The prevalence of diabetes mellitus in an adult community as determined by history or fasting hyperglycemia. American Journal of Epidemiology 1980; 111: 705-712.
Barrett-Connor E. Factors associated with the distribution of fasting plasma glucose in an adult community. American Journal of Epidemiology 1980; 112: 518-523.
Kritz-Silverstein D, Barrett-Connor E and Wingard DL. Hysterectomy, oophorectomy, and heart disease risk factors in older women. American Journal of Public Health 1997; 87: 676-680. http://dx.doi.org/10.2105/AJPH.87.4.676
Holdbrook M, Austin M and Criqui M. Cigarette smoking cessation in an upper middle class population. J Cardiac Rehab 1981; 1: 122-125.
Jones BR, Barrett-Connor E, Criqui MH and Holdbrook MJ. A community study of calorie and nutrient intake in drinkers and nondrinkers of alcohol. American Journal of Clinical Nutrition 1982; 35: 135-139.
Barrett-Connor E, Criqui MH, Klauber MR and Holdbrook M. Diabetes and hypertension in a community of older adults. American Journal of Epidemiology 1981; 113: 276-284.
Harris MI, Hadden WC, Knowler WC and Bennett PH. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 yr. Diabetes 1987; 36: 523-534. http://dx.doi.org/10.2337/diab.36.4.523
Harris MI. Impaired glucose tolerance in the U.S. population. Diabetes Care 1989; 12: 464-474. http://dx.doi.org/10.2337/diacare.12.7.464
Wingard DL, Sinsheimer P, Barrett-Connor EL and McPhillips JB. Community-based study of prevalence of NIDDM in older adults. Diabetes Care 1990: 13; 3-8. http://dx.doi.org/10.2337/diacare.13.2.S3
Institute NHB and Branch LM-A. The lipid research clinics population studies data book. US Department of Health and Human Services, Public Health Service. National Institutes of Health 1980.
